New medicine for chemotherapy nerve pain
Part of Brain & nervous system, Pain clinical trials.
This study tests a new medicine (JMKX000189) to see if it can safely reduce nerve pain, tingling, or numbness that comes from chemotherapy. If you have this side effect after cancer treatment, this trial might offer a new way to feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a confirmed solid tumor cancer (not leukemia or lymphoma).
- You must have nerve pain, tingling, or numbness caused by chemotherapy (not by other conditions like diabetes).
- Your overall health should be reasonably good (able to handle daily activities and expected to live at least 3 months).
- You should not have had major heart problems in the last 6 months, and your organ function must be adequate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This trial tests whether a spinal cord stimulator, a small device that sends gentle electrical signals to block pain, can relieve nerve pain caused by chemotherapy. If you have ongoing numbness or burning in your hands or feet after treatment, this study might help you feel better and improve your quality of life.
This trial tests a new medicine called AK135 to see if it can help reduce pain and numbness caused by chemotherapy. It is for people who have ongoing nerve problems after finishing certain cancer treatments.
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
Hear when a new CIPN - Chemotherapy-Induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.